Skip to main content

Table 1 Baseline characteristics before and after 1:1 propensity-score matching of training case to non-training case colorectal cancer resections

From: Supervised training of laparoscopic colorectal cancer resections does not adversely affect short- and long-term outcomes: a Propensity-score-matched cohort study

Ā 

Non-training cases before matching (n = 580)

Non-training cases after matching (n = 95)

Training cases (n = 95)

p

Age (median, range) in years

70 (29ā€“92)

72 (29ā€“90)

71 (27ā€“92)

0.677a

Gender

Ā Ā Ā 

0.191b

ā€ƒMale

320 (55.2%)

55 (57.9%)

46 (48.4%)

Ā 

ā€ƒFemale

260 (44.5%)

40 (42.1%)

49 (51.6%)

Ā 

BMI1 (kg/m2)

26 (17ā€“52)

26 (17ā€“43)

26 (17ā€“47)

0.959a

ASA2

Ā Ā Ā 

0.653b

ā€ƒ1

58 (10.0%)

9 (9.5%)

13 (13.7%)

Ā 

ā€ƒ2

379 (65.3%)

66 (69.5%)

62 (65.3%)

Ā 

ā€ƒ3

141 (24.3%)

20 (21.1%)

20 (21.1%)

Ā 

Tumour area

Ā Ā Ā 

0.821b

ā€ƒRectum

223 (38.4%)

28 (29.5%)

32 (33.7%)

Ā 

ā€ƒLeft-sided colon

172 (29.7%)

28 (29.5%)

26 (27.4%)

Ā 

ā€ƒRight-sided colon

185 (31.9%)

39 (41.1%)

37 (38.9%)

Ā 

Previous surgery

Ā Ā Ā 

0.424b

ā€ƒNo

391 (67.4%)

65 (68.4%)

70 (73.7%)

Ā 

ā€ƒYes

189 (32.6%)

30 (31.6%)

25 (26.3%)

Ā 

T stage

Ā Ā Ā 

0.250c

ā€ƒT0

6 (1.0%)

2 (2.1%)

0 (0.0%)

Ā 

ā€ƒT1

58 (10.0%)

8 (8.4%)

9 (9.5%)

Ā 

ā€ƒT2

134 (23.1%)

18 (18.9%)

22 (23.2%)

Ā 

ā€ƒT3

323 (55.7%)

54 (56.8%)

59 (62.1%)

Ā 

ā€ƒT4a

51 (8.8%)

12 (12.6%)

5 (5.3%)

Ā 

ā€ƒT4b

8 (1.4%)

1 (1.1%)

0 (0.0%)

Ā 

N stage

Ā Ā Ā 

0.346c

ā€ƒN0

366 (63.1%)

57 (60.0%)

65 (68.4%)

Ā 

ā€ƒN1

140 (24.1%)

24 (25.3%)

22 (23.2%)

Ā 

ā€ƒN2

74 (12.8%)

14 (14.7%)

8 (8.4%)

Ā 

AJCC3 tumour stage

Ā Ā Ā 

0.523c

ā€ƒ0

4 (7%)

1 (1.1%)

0 (0.0%)

Ā 

ā€ƒ1

150 (25.9%)

20 (21.1%)

23 (24.2%)

Ā 

ā€ƒ2

201 (34.7%)

35 (36.8%)

40 (42.1%)

Ā 

ā€ƒ3

203 (35.0%)

36 (37.9%)

27 (28.4%)

Ā 

ā€ƒ4

22 (3.8%)

3 (3.2%)

5 (5.3%)

Ā 

Radiotherapy

Ā Ā Ā 

0.771c

ā€ƒNone

534 (92.1%)

88 (92.6%)

87 (91.6%)

Ā 

ā€ƒShort course

13 (2.2%)

2 (2.1%)

4 (4.2%)

Ā 

ā€ƒLong course

31 (5.3%)

4 (4.2%)

4 (4.2%)

Ā 

ā€ƒPostoperative

2 (0.3%)

1 (1.1%)

0 (0.0%)

Ā 

Type of chemotherapy

Ā Ā Ā 

0.180c

ā€ƒNone

371 (64.0%)

56 (58.9%)

68 (71.6%)

Ā 

ā€ƒNeoadjuvant

37 (6.4%)

5 (5.3%)

3 (3.2%)

Ā 

ā€ƒAdjuvant

169 (29.1%)

34 (35.8%)

24 (25.3%)

Ā 

ā€ƒPalliative

3 (0.5%)

0

0

Ā 

Procedure

Ā Ā Ā 

0.585c

ā€ƒAnterior resection

314 (54.1%)

44 (46.3%)

45 (47.4%)

Ā 

ā€ƒSigmoid colectomy

24 (4.1%)

6 (6.3%)

1 (1.1%)

Ā 

ā€ƒLeft colectomy

14 (2.4%)

2 (2.1%)

3 (3.2%)

Ā 

ā€ƒRight colectomy

149 (25.7%)

34 (35.8%)

34 (35.8%)

Ā 

ā€ƒExtended right colectomy

35 (6.0%)

3 (3.2%)

3 (3.2%)

Ā 

ā€ƒHartmannā€™s procedure

5 (0.9%)

1 (1.1%)

1 (1.1%)

Ā 

ā€ƒAPR4

27 (4.7%)

3 (3.2%)

7 (7.4%)

Ā 

ā€ƒTotal/subtotal colectomy

5 (0.95%)

1 (1.1%)

1 (1.1%)

Ā 

ā€ƒPanproctocolectomy

7 (1.2%)

1 (1.1%)

0 (0.0%)

Ā 

Stoma

Ā Ā Ā 

0.301c

ā€ƒNo stoma

345 (59.5%)

64 (67.4%)

63 (66.3%)

Ā 

ā€ƒTemporary ileostomy

183 (31.6%)

23 (24.2%)

24 (25.3%)

Ā 

ā€ƒPermanent ileostomy

9 (1.6%)

2 (2.1%)

0 (0.0%)

Ā 

ā€ƒTemporary colostomy

7 (1.2%)

2 (2.1%)

0 (0.0%)

Ā 

ā€ƒPermanent colostomy

36 (6.2%)

4 (4.2%)

8 (8.4%)

Ā 
  1. 1Body mass index, 2American Society of Anesthetists, 3American Joint Committee on Cancer, 4abdominoperineal resection
  2. aMannā€“Whitney U test, bPearsonā€™s chi-square test, cFisherā€™s exact test